half-life is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-18. Numbers and descriptions here follow the published literature rather than marketing material.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
== Production and processing == Producing a biomaterial from raw silk generally proceeds through three stages: the fibroin is purified, dissolved into a workable solution, then shaped and stabilised into a final form. Cocoons are boiled in a mild alkaline solution, usually sodium carbonate, which removes the sericin. The degummed fibres are then dissolved, most often in concentrated lithium bromide, a salt concentrated enough to disrupt the hydrogen bonds holding the beta-sheet domains together. Dialysis against water removes the salt and leaves an aqueous fibroin solution, the common precursor for nearly everything that follows. A single solution yields a striking variety of forms. Dried as a thin layer on a surface, it produces films and coatings used in optics, in sensors and to modify the surfaces of implants. When the protein assembles into a soft, water-swollen network—a transition driven by changes in pH or temperature, by sonication or by an applied electric field—the result is a hydrogel. Freeze-drying, or casting the protein around salt crystals or gas bubbles, produces porous sponges and scaffolds whose interconnected pores allow cells to grow in three dimensions. Drawing the solution through a high electric field spins it into fine fibres, a technique known as electrospinning, which yields non-woven mats resembling the natural network surrounding cells. The same solution can also be formed into microspheres and nanoparticles for carrying and releasing drugs.
== Orthodox accounts == The first school of interpretation to emerge in the United States was "orthodox". For more than a decade after the end of the World War II, few American historians challenged the official American interpretation of the beginnings of the Cold War. The "orthodox" school places the responsibility for the Cold War on the Soviet Union and its expansion into Eastern Europe. For example, Thomas A. Bailey argued in his 1950 America Faces Russia that the breakdown of postwar peace was the result of Soviet expansionism in the immediate years following World War II. Bailey argued Joseph Stalin violated promises he had made at the Yalta Conference, imposed Soviet-dominated regimes on unwilling Eastern European populations and conspired to spread communism throughout the world. From that view, American officials were forced to respond to Soviet aggression with the Truman Doctrine, plans to contain communist subversion around the world and the Marshall Plan. Another prominent "orthodox" historian was Herbert Feis, who in his works like Churchill, Roosevelt, Stalin and From Trust to Terror: The Onset of the Cold War stated similar views. According to him, Soviet aggression in Eastern Europe in the postwar period was responsible for starting of the Cold War. Apart from this, he also argued that Franklin D. Roosevelt's policies towards Stalin and his "surrender" to Stalin's demands in the Yalta Conference paved the way for Soviet aggression and destabilized balance of power in Europe in Soviet favor.
A wide variety of foods can cause allergic reactions, but 90% of allergic responses to foods are caused by cow's milk, soy, eggs, wheat, peanuts, tree nuts, fish, and shellfish. Other food allergies, affecting less than 1 person per 10,000 population, may be considered "rare". The most common food allergy in the US population is a sensitivity to crustacea. Although peanut allergies are notorious for their severity, peanut allergies are not the most common food allergy in adults or children. Other allergens may trigger severe or life-threatening reactions and are more common when combined with asthma. Rates of allergies differ between adults and children. Children can sometimes outgrow peanut allergies. Egg allergies affect one to two percent of children but are outgrown by about two-thirds of children by the age of 5. The sensitivity is usually to proteins in the white, rather than the yolk. Milk-protein allergies—distinct from lactose intolerance—are most common in children. Approximately 60% of milk-protein reactions are immunoglobulin E–mediated, with the remaining usually attributable to inflammation of the colon. Some people are unable to tolerate milk from goats or sheep as well as from cows, and many are also unable to tolerate dairy products such as cheese. Roughly 10% of children with a milk allergy will have a reaction to beef. Lactose intolerance, a common reaction to milk, is not a form of allergy at all, but due to the absence of an enzyme in the digestive tract.
Subfamily ABCC contains thirteen members and nine of these transporters are referred to as the Multidrug Resistance Proteins (MRPs). The MRP proteins are found throughout nature and they mediate many important functions. They are known to be involved in ion transport, toxin secretion, and signal transduction. Of the nine MRP proteins, four of them, MRP4, 5, 8, 9, (ABCC4, 5, 11, and 12), have a typical ABC structure with four domains, comprising two membrane spanning domains, with each spanning domain followed by a nucleotide binding domain. These are referred to as short MRPs. The remaining 5 MRP's (MRP1, 2, 6, 7) (ABCC1, 2, 3, 6 and 10) are known as long MRPs and feature an additional fifth domain at their N terminus. CFTR, the transporter involved in the disease cystic fibrosis, is also considered part of this subfamily. Cystic fibrosis occurs upon mutation and loss of function of CFTR. The sulfonylurea receptors (SUR), involved in insulin secretion, neuronal function, and muscle function, are also part of this family of proteins. Mutations in SUR proteins are a potential cause of Neonatal diabetes mellitus. SUR is also the binding site for drugs such as sulfonylureas and potassium-channel openers activators such as diazoxide.
Lead (82Pb) has four observationally stable isotopes: 204Pb, 206Pb, 207Pb, 208Pb. Lead-204 is entirely a primordial nuclide and is not a radiogenic nuclide. The three isotopes lead-206, lead-207, and lead-208 represent the ends of three decay chains: the uranium series (or radium series), the actinium series, and the thorium series, respectively; a fourth decay chain, the neptunium series, terminates with the thallium isotope 205Tl. The three series terminating in lead represent the decay chain products of long-lived primordial 238U, 235U, and 232Th. Each isotope also occurs, to some extent, as primordial isotopes that were made in supernovae, rather than radiogenically as daughter products. The fixed ratio of lead-204 to the primordial amounts of the other lead isotopes may be used as the baseline to estimate the extra amounts of radiogenic lead present in rocks as a result of decay from uranium and thorium. This is the basis for lead–lead dating and uranium–lead dating. The longest-lived radioisotopes, both decaying by electron capture, are 205Pb with a half-life of 17.0 million years and 202Pb with a half-life of 52,500 years. A shorter-lived naturally occurring radioisotope, 210Pb with a half-life of 22.2 years, is useful for studying the sedimentation chronology of environmental samples on time scales shorter than 100 years. The heaviest stable isotope, 208Pb, belongs to this element. (The more massive 209Bi, long considered to be stable, actually has a half-life of 2.01×1019 years.) 208Pb is also a doubly magic isotope, as it has 82 protons and 126 neutrons.
Sources: en.wikipedia.org
The vorticity equation of fluid dynamics describes the evolution of the vorticity ω of a particle of a fluid as it moves with its flow; that is, the local rotation of the fluid (in terms of vector calculus this is the curl of the flow velocity). The governing equation is:where D/Dt is the material derivative operator, u is the flow velocity, ρ is the local fluid density, p is the local pressure, τ is the viscous stress tensor and B represents the sum of the external body forces. The first source term on the right hand side represents vortex stretching. The equation is valid in the absence of any concentrated torques and line forces for a compressible, Newtonian fluid. In the case of incompressible flow (i.e., low Mach number) and isotropic fluids, with conservative body forces, the equation simplifies to the vorticity transport equation:
The 22nd Brigade was deployed as a flank guard, sweeping down the Tanlwe Chaung before hooking around to the Taungup Chaung and ultimately the road to Prome; this move was intended to cut Japanese units to the north off from the Irrawaddy Delta to the south, where most of the key battles were being fought. 1RAR patrolled the area during March and April 1945 and was involved in several contacts. On 20 April it assembled at a point overlooking Tanlwe Chaung, where it was shelled by Japanese artillery and mortars dug in atop two high features to the south. On the morning of 26 April, after a few days of patrols, 1RAR took the lead in what became the Battle of Tanlwe Chaung; after about half an hour of bombing, strafing and artillery bombardment of the Japanese positions, elements of A and D Companies, 1RAR charged up the slopes and routed much of the Japanese garrison before taking both hills. Seven RAR men were killed in the action and 22 were wounded, mostly from D Company; an officer was also injured. An officer of the RAR recalled the battles of April 1945 around Taungup and Tanlwe Chaung as extremely intense:
Fibromyalgia (FM) is a long-term condition characterised by widespread chronic pain. Other symptoms can include fatigue, trouble thinking or remembering, waking up tired (unrefreshed), pain or cramps in the lower abdomen, depression, or headache. The causes of fibromyalgia are unknown, with several pathophysiologies proposed. Fibromyalgia is estimated to affect 2 to 4% of the population. Women are affected at a higher rate than men. Rates appear similar across areas of the world and among varied cultures. Fibromyalgia was first recognised in the 1950s, and defined in 1990, with updated criteria in 2011, 2016, and 2019. The treatment of fibromyalgia is symptomatic and multidisciplinary. Aerobic and strengthening exercise is recommended. Duloxetine, milnacipran, and pregabalin can give short-term pain relief to some people with FM. Symptoms of fibromyalgia persist long-term in most patients. Fibromyalgia is associated with a significant economic and social burden, and it can cause substantial functional impairment among people with the condition. People with fibromyalgia can be subjected to significant stigma and doubt about the legitimacy of their symptoms, including in the healthcare system. FM is associated with relatively high suicide rates.
Lime can be manufactured in countercurrent furnaces allowing the heat to reach high temperatures using low cost, low temperature burning fuel. Historically this was developed by the Japanese in certain types of the Anagama kiln. The kiln is built in stages, where fresh air coming to the fuel is passed downwards while the smoke and heat is pushed up and out. The heat does not leave the kiln, but is transferred back to the incoming air, and thus slowly builds up to 3,000 °C (5,430 °F) and more.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.